Number of Shares
51,406.58
Current Holdings Value*
$4.52 Mil
% of Portfolio
0.87%
Total Estimate Gain
$136.68 Mil
% of Total Estimate Gain
304.19%

Atlas Venture Life Science Advisors, LLC's Aerovate Therapeutics Inc Holding Summary

As of 2025-03-31, Atlas Venture Life Science Advisors, LLC held 51,406.58 shares of Aerovate Therapeutics Inc(AVTE), totaling $4.52 Mil. This investment constitutes 0.87% of their stock portfolio, and Atlas Venture Life Science Advisors, LLC now holds 6.21% of the outstanding Aerovate Therapeutics Inc(AVTE) stock.

The initial trade took place in 2021Q4. And since then Atlas Venture Life Science Advisors, LLC has made 1 purchases of AVTE, at an average price of $14.38, for a total of 3.13 Mil shares. In addition, there have been 4 sales at an average price of $57.51 for 3.07 Mil shares. Based on historical transaction data and AVTE's current price of $93.80, Atlas Venture Life Science Advisors, LLC's estimated gain on his AVTE holdings is $136.68 Mil, reflecting a 304.19% gain to date.

Atlas Venture Life Science Advisors, LLC AVTE ($93.80) Holding Chart

Atlas Venture Life Science Advisors, LLC AVTE ($93.80) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1